Evidence map›Paper›PMID 34914359›Full record

ArticleBiomacromolecules2022

Intracellular Dynamin Elastin-like Polypeptides Assemble into Rodlike, Spherical, and Reticular Dynasomes.

Hugo Avila, Anh Truong, David Tyrpak, Shin-Jae Park, Siqi Lei, Yaocun Li, Curtis Okamoto, Sarah Hamm-Alvarez, J Andrew MacKay

Open access · greenAbstract read
In one paragraph

Article in Biomacromolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Hugo AvilaDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California School of Pharmacy, Los Angeles 90089, United States.ORCID 0000-0003-3742-589X
Anh TruongDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California School of Pharmacy, Los Angeles 90089, United States.
David TyrpakDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California School of Pharmacy, Los Angeles 90089, United States.
Shin-Jae ParkDepartment of Biomedical Engineering, University of Southern California Viterbi School of Engineering, Los Angeles 90089, United States.
Siqi LeiDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California School of Pharmacy, Los Angeles 90089, United States.
Yaocun LiDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California School of Pharmacy, Los Angeles 90089, United States.
Curtis OkamotoDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California School of Pharmacy, Los Angeles 90089, United States.
Sarah Hamm-AlvarezDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California School of Pharmacy, Los Angeles 90089, United States.ORCID 0000-0001-8195-5703
J Andrew MacKayDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California School of Pharmacy, Los Angeles 90089, United States.ORCID 0000-0002-3626-1654
University of Southern California · US

Funding

USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Fumito Ito · 1985 to 2026
$181.4M
Ophthalmic Therapeutics Engineering CoreP30EY029220 · NEI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Mahnaz Shahidi · 2018 to 2026
$6.5M
Intracellular switching using genetically engineered protein microdomainsR01GM114839 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MACKAY, JOHN ANDREW · 2015 to 2019
$1.9M
Novel temperature-responsive fusions of clathrin and caveolin to explore TGF-beta mediated fibrosisF31DK118881 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TYRPAK, DAVID RYAN · 2018 to 2019
$77k
NCI NIH HHS P30 CA014089NEI NIH HHS P30 EY029220NIDDK NIH HHS F31 DK118881NIGMS NIH HHS R01 GM114839
6 · The paper itself

Abstract

Dynamin (DNM) is a family of large GTPases possessing a unique mechanical ability to "pinch" off vesicles entering cells. DNM2 is the most ubiquitously expressed member of the DNM family. We developed a novel tool based on elastin-like polypeptide (ELP) technology to quickly, precisely, and reversibly modulate the structure of DNM2. ELPs are temperature-sensitive biopolymers that self-assemble into microdomains above sharp transition temperatures. When linked together, DNM2 and a temperature-sensitive ELP fusion organize into a range of distinct temperature-dependent structures above a sharp transition temperature, which were not observed with wild-type DNM2 or a temperature-insensitive ELP fusion control. The structures comprised three different morphologies, which were prevalent at different temperature ranges. The size of these structures was influenced by an inhibitor of the DNM2 GTPase activity, dynasore; furthermore, they appear to entrap co-expressed cytosolic ELPs. Having demonstrated an unexpected diversity of morphologically distinct structures, DNM2-ELP fusions may have applications in the exploration of dynamin-dependent biology.

Indexed as

ElastinPeptidesDynaminsTemperatureTransition TemperatureDynaminsElastinPeptides

Identifiers

PMID34914359
PMCPMC9159747
OpenAlexW4200094982

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.